Found 4 matching trials
Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC) PHASE1 This is a Phase I study in participants with superficial or nodular Basal C...
Show More Location
The Center for Clinical and Cosmetic Research
Learn More & Join Trial
Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL) PHASE1 The study hypothesis is that in situ MNA-directed chemo-immunotherapy using...
Show More Location
UPMC Department of Dermatology
Learn More & Join Trial
Phase 2 Study Evaluating the Safety and Efficacy of Microneedle-mediated Delivery of Doxorubicin (D-MNA) in Patients With Nodular Basal Cell Carcinoma. PHASE2 This Phase 2 study evaluates the safety and efficacy of microneedle array (...
Show More Location
Rao Dermotology West Coast -Site #4
Learn More & Join Trial
Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC) PHASE1 The purpose of this study is to test a new method of experimental treatment...
Show More Location
University of Pittsburgh Medical Center
Learn More & Join Trial